BEGIN:VCALENDAR
PRODID:-//github.com/rianjs/ical.net//NONSGML ical.net 4.0//EN
VERSION:2.0
BEGIN:VTIMEZONE
TZID:Pacific Standard Time
X-LIC-LOCATION:America/Los_Angeles
BEGIN:STANDARD
DTSTART:20231105T020000
RRULE:FREQ=YEARLY;BYDAY=1SU;BYMONTH=11
TZNAME:PST
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
END:STANDARD
BEGIN:DAYLIGHT
DTSTART:20240310T020000
RRULE:FREQ=YEARLY;BYDAY=2SU;BYMONTH=3
TZNAME:PDT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
END:DAYLIGHT
END:VTIMEZONE
BEGIN:VEVENT
DESCRIPTION:2022 Annual Meeting by the ΊΓΙ«ΟΘΙϊ\n\nTi
 tle: Industry Therapeutic Update from Bristol Myers Squibb: ZEPOSIA: An O
 ral Option for Patients With Relapsing Forms of Multiple Sclerosis\n\nAcc
 ess URL: /MSA/Public/Events/GetEventURL/14747\n\nLearn
  More About This Event: /MSA/Public/Events/Details/147
 47
DTEND;TZID=Pacific Standard Time:20220405T220000
DTSTAMP:20250503T210707Z
DTSTART;TZID=Pacific Standard Time:20220405T190000
LOCATION:/MSA/Public/Events/GetEventURL/14747
SEQUENCE:0
SUMMARY:AAN: Industry Therapeutic Update from Bristol Myers Squibb: ZEPOSI
 A: An Oral Option for Patients With Relapsing Forms of Multiple Sclerosis
UID:cc37ccbd-e6a4-43de-b153-fdeeefa86c37
END:VEVENT
END:VCALENDAR